Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 12, Issue 4, Pages 371-384
Publisher
Informa UK Limited
Online
2012-03-26
DOI
10.1586/ern.12.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune mechanisms of new therapeutic strategies in multiple sclerosis—A focus on alemtuzumab
- (2011) Luisa Klotz et al. CLINICAL IMMUNOLOGY
- Immune mechanisms of new therapeutic strategies in MS — Teriflunomide
- (2011) Malte C. Claussen et al. CLINICAL IMMUNOLOGY
- The impact of parasite infections on the course of multiple sclerosis
- (2011) Jorge Correale et al. JOURNAL OF NEUROIMMUNOLOGY
- Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis
- (2011) Kelly Claire Simon et al. JOURNAL OF NEUROLOGY
- Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study
- (2011) E Le Page et al. Multiple Sclerosis Journal
- A critical appraisal of treatment decisions in multiple sclerosis—old versus new
- (2011) Bernd C. Kieseier et al. Nature Reviews Neurology
- Phase III dose-comparison study of glatiramer acetate for multiple sclerosis
- (2010) Giancarlo Comi et al. ANNALS OF NEUROLOGY
- A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis
- (2010) Samia J. Khoury et al. ARCHIVES OF NEUROLOGY
- Oral Therapies for Multiple Sclerosis
- (2010) Ralf Gold CNS DRUGS
- Emerging Oral Therapies in Multiple Sclerosis
- (2010) Devon Conway et al. Current Neurology and Neuroscience Reports
- Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update
- (2010) Kenneth P Johnson Expert Opinion on Drug Metabolism & Toxicology
- Treating multiple sclerosis with monoclonal antibodies: a 2010 update
- (2010) Mathias Buttmann Expert Review of Neurotherapeutics
- Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
- (2010) Alberto Ascherio et al. Journal of Neuroimmune Pharmacology
- Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing–remitting or chronic EAE
- (2010) Rina Aharoni et al. JOURNAL OF NEUROIMMUNOLOGY
- Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study
- (2010) G. Anderson et al. JOURNAL OF NEUROLOGY
- Effect of Oral Antihistamine on Local Injection Site Reactions With Self-Administered Glatiramer Acetate
- (2010) Gabriel Pardo et al. JOURNAL OF NEUROSCIENCE NURSING
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- Vitamin D and multiple sclerosis
- (2010) Alberto Ascherio et al. LANCET NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome
- (2010) B. Ben-Zeev et al. MEDICAL HYPOTHESES
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
- (2010) G. Comi et al. Multiple Sclerosis Journal
- Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
- (2010) C. Ford et al. Multiple Sclerosis Journal
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opportunistic infections and other risks with newer multiple sclerosis therapies
- (2009) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
- (2009) Mrinalini Kala et al. EXPERIMENTAL NEUROLOGY
- The glatiramoid class of immunomodulator drugs
- (2009) Haim Varkony et al. EXPERT OPINION ON PHARMACOTHERAPY
- Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms
- (2009) J. Correale et al. JOURNAL OF IMMUNOLOGY
- Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis
- (2009) Juergen Haas et al. JOURNAL OF NEUROIMMUNOLOGY
- Impact of Warm Compresses on Local Injection-Site Reactions with Self-Administered Glatiramer Acetate
- (2009) Helen Jolly et al. JOURNAL OF NEUROSCIENCE NURSING
- Glatiramer acetate treatment in PPMS: Why males appear to respond favorably
- (2009) Jerry S. Wolinsky et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis
- (2009) K. Claire Simon et al. Multiple Sclerosis Journal
- Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study
- (2009) D. Cadavid et al. NEUROLOGY
- The mechanism of action of glatiramer acetate treatment in multiple sclerosis
- (2009) M. K. Racke et al. NEUROLOGY
- GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study
- (2009) A. D. Goodman et al. NEUROLOGY
- Helminth infections associated with multiple sclerosis induce regulatory B cells
- (2008) Jorge Correale et al. ANNALS OF NEUROLOGY
- CD4+CD25+FoxP3+PD1− regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy
- (2008) Marina Saresella et al. FASEB JOURNAL
- The therapeutic effect of TV-5010 in a murine model of inflammatory bowel disease — Dextran induced colitis
- (2008) Rina Aharoni et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Interplay Between Effector Th17 and Regulatory T Cells
- (2008) Amit Awasthi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis
- (2008) S BEGUMHAQUE et al. JOURNAL OF NEUROIMMUNOLOGY
- Glatiramer Acetate
- (2008) François Blanchette et al. JOURNAL OF NEUROLOGY
- Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS
- (2008) D. L. Arnold et al. JOURNAL OF NEUROLOGY
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis
- (2008) N De Stefano et al. Multiple Sclerosis Journal
- Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
- (2008) T Vollmer et al. Multiple Sclerosis Journal
- Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
- (2008) F Di Pauli et al. Multiple Sclerosis Journal
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
- (2008) R. Aharoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now